A detailed history of Terra Nova Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Terra Nova Asset Management LLC holds 1,921 shares of ABBV stock, worth $344,243. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,921
Previous 1,920 0.05%
Holding current value
$344,243
Previous $329,000 15.2%
% of portfolio
0.28%
Previous 0.27%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $163 - $199
1 Added 0.05%
1,921 $379,000
Q2 2024

Jul 15, 2024

BUY
$154.79 - $180.76 $309 - $361
2 Added 0.1%
1,920 $329,000
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $10,068 - $11,472
-63 Reduced 3.18%
1,918 $349,000
Q4 2023

Jan 18, 2024

SELL
$137.6 - $154.97 $160,028 - $180,230
-1,163 Reduced 36.99%
1,981 $306,000
Q2 2023

Jul 21, 2023

SELL
$132.51 - $164.9 $276,283 - $343,816
-2,085 Reduced 39.87%
3,144 $423,000
Q1 2023

Apr 12, 2023

SELL
$144.61 - $166.54 $2,169 - $2,498
-15 Reduced 0.29%
5,229 $833,000
Q4 2022

Jan 23, 2023

SELL
$138.31 - $165.87 $20,054 - $24,051
-145 Reduced 2.69%
5,244 $0
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $21,070 - $24,167
157 Added 3.0%
5,389 $723,000
Q2 2022

Jul 22, 2022

BUY
$137.62 - $174.96 $38,671 - $49,163
281 Added 5.68%
5,232 $801,000
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $4,223 - $5,240
-32 Reduced 0.64%
4,951 $803,000
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $2,041 - $2,582
19 Added 0.38%
4,983 $675,000
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $17,130 - $19,445
161 Added 3.35%
4,964 $535,000
Q2 2021

Aug 06, 2021

SELL
$105.21 - $117.21 $6,838 - $7,618
-65 Reduced 1.34%
4,803 $541,000
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $1,841 - $2,027
18 Added 0.37%
4,868 $527,000
Q4 2020

Jan 29, 2021

SELL
$80.49 - $108.67 $815,846 - $1.1 Million
-10,136 Reduced 67.64%
4,850 $520,000
Q4 2018

Feb 15, 2019

SELL
$77.85 - $96.01 $71,154 - $87,753
-914 Reduced 5.75%
14,986 $1.38 Million
Q3 2018

Oct 29, 2018

SELL
$88.91 - $98.84 $69,794 - $77,589
-785 Reduced 4.7%
15,900 $1.5 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $118,150 - $139,798
1,316 Added 8.56%
16,685 $1.55 Million
Q1 2018

Apr 17, 2018

BUY
$92.01 - $123.21 $261,492 - $350,162
2,842 Added 22.69%
15,369 $1.46 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $702,150 - $769,966
7,840 Added 167.27%
12,527 $1.21 Million
Q3 2017

Oct 24, 2017

BUY
$69.85 - $89.22 $327,386 - $418,174
4,687
4,687 $416,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Terra Nova Asset Management LLC Portfolio

Follow Terra Nova Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Terra Nova Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Terra Nova Asset Management LLC with notifications on news.